General Pathology — MCQs

General Pathology Indian Medical PG Practice Questions and MCQs

Question 991: What is a characteristic bone marrow finding in myelofibrosis?

A. Leucoerythroblastosis
B. Tear drop cells
C. Leucocytopenia
D. All of the above (Correct Answer)

Explanation: **Explanation:** Primary Myelofibrosis (PMF) is a chronic myeloproliferative neoplasm characterized by the replacement of normal bone marrow with fibrous tissue (collagen), primarily mediated by the release of fibrogenic factors like **TGF-̢** from neoplastic megakaryocytes [1], [3]. **Why "All of the above" is correct:** 1. **Leucoerythroblastosis:** As the bone marrow becomes fibrotic, the normal "blood-bone barrier" is disrupted. This forces immature red cells (nucleated RBCs) and immature white cells (myelocytes, metamyelocytes) to be prematurely released into the peripheral blood [1]. 2. **Tear drop cells (Dacrocytes):** As red blood cells attempt to squeeze through the narrow, fibrotic slits of the marrow or the distorted vasculature of the enlarging spleen (extramedullary hematopoiesis), they undergo mechanical stretching, resulting in their characteristic "tear drop" shape [1]. 3. **Leucocytopenia:** While early stages of PMF may show leucocytosis, the **spent phase** (advanced fibrosis) is characterized by progressive bone marrow failure. This leads to pancytopenia, including a decrease in white blood cell counts (leucocytopenia) [3]. **Clinical Pearls for NEET-PG:** * **Dry Tap:** On bone marrow aspiration, PMF typically results in a "dry tap" due to extensive fibrosis. Diagnosis requires a **Trephine Biopsy**. * **Silver Stain:** Reticulin fibers are highlighted using **Gomori’s silver stain**. * **Splenomegaly:** PMF often presents with **massive splenomegaly** due to compensatory extramedullary hematopoiesis [1], [3]. * **Genetic Markers:** Look for **JAK2 V617F** (found in ~50-60% of cases), CALR, or MPL mutations [1], [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 627-629. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 614-615. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 614-616.

Question 992: Increased susceptibility to breast cancer is likely to be associated with a mutation in the following gene?

A. P53 (Correct Answer)
B. BRCA-1
C. Retinoblastoma (Rb)
D. H-Ras

Explanation: **Explanation:** The correct answer is **P53**. While several genes are linked to breast cancer, the question asks for the gene most broadly associated with increased susceptibility across various syndromic and sporadic contexts. **1. Why P53 is Correct:** The **TP53** gene, located on chromosome 17p, encodes the p53 protein, known as the "Guardian of the Genome." It regulates the cell cycle, DNA repair, and apoptosis [1][2]. Germline mutations in TP53 cause **Li-Fraumeni Syndrome**, a rare autosomal dominant disorder characterized by a high predisposition to a wide spectrum of tumors, most notably **early-onset breast cancer**, sarcomas, brain tumors, and adrenocortical carcinomas [2]. Somatic mutations of P53 are also the most common genetic alteration found in human cancers, including sporadic breast cancer [2]. **2. Why Incorrect Options are Wrong:** * **BRCA-1:** While BRCA-1 is strongly associated with hereditary breast and ovarian cancer, it is primarily linked to specific familial clusters [4]. In the context of general "increased susceptibility" across multiple cancer syndromes, P53 is often considered the more fundamental tumor suppressor. (Note: In many clinical exams, if Li-Fraumeni is the focus, P53 is the keyed answer). * **Retinoblastoma (Rb):** The Rb gene (chromosome 13q) is the "Governor of the Cell Cycle." Mutations primarily predispose individuals to retinoblastoma and osteosarcoma, not typically breast cancer [2]. * **H-Ras:** This is a proto-oncogene involved in signaling pathways. While mutations occur in various cancers (like bladder or kidney), it is not a primary susceptibility gene for breast cancer [3]. **High-Yield Clinical Pearls for NEET-PG:** * **Li-Fraumeni Syndrome:** Remember the "SBLA" mnemonic (Sarcoma, Breast, Leukemia, Adrenal gland). * **P53 Mechanism:** It acts at the **G1-S checkpoint** by inducing p21, which inhibits CDK-cyclin complexes [1][2]. * **Most Common Mutation:** TP53 is the most frequently mutated gene in human cancer overall [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 297-298. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 227-228. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 303-304. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Breast, pp. 1058-1059.

Question 993: In genetic deficiency of myeloperoxidase (MPO), the increased susceptibility to infection is due to:

A. Defective production of prostaglandins
B. Defective rolling of neutrophils
C. Inability to produce hydroxyl halide radicals (Correct Answer)
D. Inability to produce hydrogen peroxide

Explanation: ### Explanation **Correct Answer: C. Inability to produce hydroxyl halide radicals** The killing of bacteria by neutrophils occurs primarily through the **H₂O₂-MPO-halide system**, which is the most efficient bactericidal mechanism. [1] 1. During phagocytosis, there is a "respiratory burst" where NADPH oxidase converts oxygen into superoxide ($O_2^{\bullet-}$), which then dismutates into **Hydrogen Peroxide ($H_2O_2$)**. 2. The enzyme **Myeloperoxidase (MPO)**, present in the azurophilic granules of neutrophils, then converts $H_2O_2$ and a halide ion (usually chloride) into **Hypochlorous acid ($HOCl^{\bullet}$)**—a potent hydroxyl halide radical (bleach). [1] 3. In MPO deficiency, neutrophils can produce $H_2O_2$ but cannot convert it to $HOCl^{\bullet}$. This leads to a delayed killing capacity, specifically increasing susceptibility to *Candida albicans* infections. --- ### Analysis of Incorrect Options: * **A. Defective production of prostaglandins:** Prostaglandins are mediators of inflammation (vasodilation and pain) derived from arachidonic acid via the COX pathway. They are not involved in the intracellular killing mechanism of neutrophils. * **B. Defective rolling of neutrophils:** Rolling is mediated by **Selectins** (E, P, and L-selectin). Defects in rolling are seen in **Leukocyte Adhesion Deficiency Type 2 (LAD-2)**, not MPO deficiency. * **D. Inability to produce hydrogen peroxide:** This is the hallmark of **Chronic Granulomatous Disease (CGD)**, caused by a deficiency in **NADPH oxidase**. In MPO deficiency, $H_2O_2$ production remains intact. --- ### High-Yield Clinical Pearls for NEET-PG: * **MPO Deficiency:** Most patients are clinically asymptomatic despite the defect, except for an increased risk of disseminated Candidiasis (especially in diabetics). * **NBT Test (Nitroblue Tetrazolium):** It remains **positive** (normal) in MPO deficiency because the respiratory burst ($H_2O_2$ production) is intact. It is **negative** in CGD. * **Dihydrorhodamine (DHR) Flow Cytometry:** The current gold standard for diagnosing CGD; it would also be normal in isolated MPO deficiency. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 91-92.

Question 994: Apoptosis is initiated by?

A. Caspases (Correct Answer)
B. DNA
C. Antibodies
D. RAS Kinase

Explanation: **Explanation:** **Apoptosis**, or programmed cell death, is a highly regulated process characterized by the activation of a specific family of enzymes called **Caspases** (Cysteine-aspartic proteases) [1]. 1. **Why Caspases are correct:** Caspases are the "executioners" of apoptosis. They exist as inactive zymogens (pro-caspases) and, once activated, initiate a proteolytic cascade [1]. They are divided into **Initiators** (Caspase 8, 9, 10) and **Executioners** (Caspase 3, 6, 7). Executioner caspases cleave structural proteins and activate endonucleases, leading to the characteristic morphological changes of apoptosis (cell shrinkage, chromatin condensation, and formation of apoptotic bodies). 2. **Why other options are incorrect:** * **DNA:** While DNA fragmentation (laddering) is a hallmark *result* of apoptosis, DNA itself does not initiate the process [2]. * **Antibodies:** These are part of the humoral immune response and are involved in Type II and Type III hypersensitivity or opsonization, but they do not directly initiate the intracellular apoptotic machinery. * **RAS Kinase:** This is a proto-oncogene involved in cell signaling for growth and proliferation. Mutations in RAS typically lead to uncontrolled cell growth (cancer) rather than cell death. **NEET-PG High-Yield Pearls:** * **Intrinsic (Mitochondrial) Pathway:** Initiated by **Caspase 9**. Regulated by the Bcl-2 family (Pro-apoptotic: Bax, Bak; Anti-apoptotic: Bcl-2, Bcl-xL) [1]. * **Extrinsic (Death Receptor) Pathway:** Initiated by **Caspase 8 or 10**. Involves Fas-FasL or TNF-TNFR1 binding [1]. * **Common Executioner:** **Caspase 3** is the most important executioner caspase for both pathways. * **Morphology:** Apoptosis involves **no inflammation** (unlike necrosis) and the cell membrane remains intact. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 64-67. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 310.

Question 995: Which of the following are features of shock?

A. Decreased GFR, Increased renin, Increased lactate (Correct Answer)
B. Decreased GFR, Increased renin, Decreased renin
C. Decreased renin, Decreased cortisol, Increased lactate
D. Decreased GFR, Decreased cortisol, Increased lactate

Explanation: **Explanation:** Shock is a state of systemic hypoperfusion caused by a reduction in either cardiac output or effective circulating blood volume [1]. This leads to tissue hypoxia and a shift from aerobic to anaerobic metabolism [1]. **1. Why Option A is Correct:** * **Decreased GFR:** In shock, systemic hypotension leads to reduced renal blood flow [3]. This triggers a drop in the Glomerular Filtration Rate (GFR), often manifesting clinically as oliguria or anuria [1], [3]. * **Increased Renin:** To compensate for low blood pressure and reduced sodium delivery to the macula densa, the juxtaglomerular apparatus releases **Renin** [2]. This activates the Renin-Angiotensin-Aldosterone System (RAAS) to promote fluid retention and vasoconstriction [2]. * **Increased Lactate:** Due to inadequate oxygen delivery, cells switch to **anaerobic glycolysis** [1]. The end product of this pathway is lactic acid; thus, elevated serum lactate is a hallmark biomarker of tissue hypoperfusion and metabolic acidosis in shock [1]. **2. Why Other Options are Wrong:** * **Options B & C:** These suggest "Decreased Renin." In shock, the body never suppresses renin; it actively stimulates it to maintain blood pressure [2]. * **Options C & D:** These suggest "Decreased Cortisol." Shock is a major systemic stressor that activates the HPA axis, leading to **increased cortisol** levels to maintain vascular tone and glucose availability [2]. **NEET-PG High-Yield Pearls:** * **Stages of Shock:** Non-progressive (compensated), Progressive (tissue hypoperfusion), and Irreversible (cellular injury) [1]. * **Warm vs. Cold Shock:** Septic shock (early) presents with vasodilation (warm extremities), while Cardiogenic and Hypovolemic shock present with vasoconstriction (cold, clammy skin). * **Morphological Hallmarks:** Shock lung (Diffuse Alveolar Damage), Shock kidney (Acute Tubular Necrosis), and Centrilobular necrosis in the liver [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, p. 144. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 420-421. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 149-150.

Question 996: What term describes an abnormal chromosomal number that is an exact multiple of 23?

A. Euploidy (Correct Answer)
B. Aneuploidy
C. Mosaicism
D. Trisomy

Explanation: **Explanation:** The correct answer is **Euploidy (Option A)**. **1. Why Euploidy is correct:** In human genetics, the haploid number ($n$) is 23. **Euploidy** refers to a state where a cell contains a total chromosome count that is an exact integral multiple of the haploid number ($n, 2n, 3n$, etc.). For example, a normal diploid cell ($2n = 46$) and a triploid cell ($3n = 69$) are both considered euploid because they are exact multiples of 23. **2. Why other options are incorrect:** * **Aneuploidy (Option B):** This refers to a chromosomal number that is **not** an exact multiple of 23 [1]. It usually involves the addition or loss of one or two chromosomes (e.g., $2n+1 = 47$ or $2n-1 = 45$). The most common causes are non-disjunction during meiosis [1]. * **Mosaicism (Option C):** This describes the presence of two or more populations of cells with different genotypes in one individual, derived from a single zygote (e.g., some cells are 46,XX while others are 47,XX,+21) [1]. * **Trisomy (Option D):** This is a specific type of aneuploidy where there are three copies of a particular chromosome instead of two (e.g., Trisomy 21) [2]. The total count is 47, which is not a multiple of 23 [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause of Aneuploidy:** Meiotic non-disjunction (usually in Maternal Meiosis I). * **Polyploidy:** A type of euploidy where there are three or more sets of chromosomes (Triploidy $3n$, Tetraploidy $4n$). It is generally incompatible with life and is a frequent cause of spontaneous abortions [2]. * **Monosomy:** Loss of a single chromosome ($2n-1$). Autosomal monosomies are lethal; the only viable monosomy in humans is **Turner Syndrome (45,XO)** [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 168-171. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 92-93.

Question 997: Retinoblastoma is associated with which of the following?

A. Osteosarcoma (Correct Answer)
B. Hepatocellular carcinoma
C. Squamous cell carcinoma
D. Osteoclastoma

Explanation: The association between **Retinoblastoma** and **Osteosarcoma** is a classic example of the "Two-Hit Hypothesis" involving the **RB1 gene** (located on chromosome 13q14) [1]. In the hereditary form of Retinoblastoma, a child inherits one defective copy of the RB1 tumor suppressor gene in all somatic cells (the first "hit"). A second mutation (the second "hit") in the retinal cells leads to Retinoblastoma [2]. Because the RB1 mutation is present in every cell of the body, these patients are at a significantly increased risk for secondary malignancies later in life, most notably **Osteosarcoma**, which typically occurs in the second decade of life [4]. **Analysis of Options:** * **A. Osteosarcoma (Correct):** This is the most common secondary primary tumor in survivors of hereditary retinoblastoma, occurring due to the germline RB1 mutation [4]. * **B. Hepatocellular carcinoma:** This is primarily associated with Hepatitis B/C, cirrhosis, or Aflatoxin B1, not the RB1 pathway. * **C. Squamous cell carcinoma:** While common in various organs, it is typically linked to HPV, smoking, or UV radiation, rather than hereditary retinoblastoma. * **D. Osteoclastoma (Giant Cell Tumor):** This is a benign but locally aggressive bone tumor. It does not share the same genetic link with the RB1 gene as Osteosarcoma does. **High-Yield Clinical Pearls for NEET-PG:** * **RB1 Gene:** The first tumor suppressor gene discovered; it regulates the **G1-S phase** transition of the cell cycle [3]. * **Knudson’s Hypothesis:** Explains why hereditary cases are often bilateral and occur earlier than sporadic cases [1]. * **Other Associations:** Besides Osteosarcoma, survivors are also at risk for **Pineoblastoma** (Trilateral Retinoblastoma) and soft tissue sarcomas. * **Histology:** Look for **Flexner-Wintersteiner rosettes** (specific for Retinoblastoma). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 298-300. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 227-228. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 297-298. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, pp. 1200-1202.

Question 998: Most common cause of Down's syndrome is:

A. Monosomy 21
B. Trisomy 21 (Correct Answer)
C. Robertsonian translocation
D. Mosaicism

Explanation: **Explanation:** Down’s syndrome (Trisomy 21) is the most common chromosomal disorder and a leading cause of intellectual disability [1]. **1. Why Trisomy 21 is the Correct Answer:** The most common cause of Down’s syndrome (occurring in **95% of cases**) is **Meiotic Nondisjunction**. This results in an extra copy of chromosome 21 in every cell of the body (Karyotype: 47, XX/XY +21) [3]. The failure of chromosomes to separate occurs most frequently during **Maternal Meiosis I**, and the risk increases significantly with advanced maternal age (>35 years) [1]. **2. Analysis of Incorrect Options:** * **Monosomy 21 (A):** This refers to the loss of one chromosome 21. Autosomal monosomies are generally incompatible with life and lead to early spontaneous abortion [2]. * **Robertsonian Translocation (C):** This accounts for approximately **3-4%** of cases. It involves the long arm of chromosome 21 attaching to another acrocentric chromosome (usually 14 or 22). Unlike nondisjunction, this type can be inherited from a carrier parent and is **not** related to maternal age [4]. * **Mosaicism (D):** This accounts for about **1-2%** of cases. It occurs due to **mitotic nondisjunction** during early fetal development, resulting in two cell lines (one normal 46-chromosome line and one trisomic 47-chromosome line). These patients often have a milder phenotype [4]. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cardiac defect:** Atrioventricular Septal Defect (Endocardial cushion defect). * **Gastrointestinal association:** Duodenal atresia ("Double bubble" sign). * **Hematological risk:** Increased risk of **ALL** (after age 5) and **AML-M7** (before age 5). * **Early-onset Alzheimer’s:** Due to the APP (Amyloid Precursor Protein) gene being located on chromosome 21. * **Screening:** Low AFP, low Estriol, and high hCG/Inhibin-A (Quadruple test). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 40-41. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 168-169. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 171-172. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 170-171.

Question 999: Down's syndrome is associated with which of the following?

A. Congenital heart disease, Acute lymphoblastic leukemia, Early onset Alzheimer's disease (Correct Answer)
B. Acute lymphoblastic leukemia, Early onset Alzheimer's disease, CNS tumors, Infection
C. Early onset Alzheimer's disease, CNS tumors, Infection
D. Congenital heart disease, CNS tumors, Infection

Explanation: **Explanation:** Down’s Syndrome (Trisomy 21) is the most common chromosomal disorder and involves multiple organ systems due to the overexpression of genes on Chromosome 21 [3]. **Why Option A is correct:** 1. **Congenital Heart Disease (CHD):** Occurs in approximately 40-50% of patients. The most characteristic lesion is an **Atrioventricular Septal Defect (Endocardial Cushion Defect)**, followed by VSD and ASD. 2. **Acute Lymphoblastic Leukemia (ALL):** Children with Down’s syndrome have a 10-20 fold increased risk of developing acute leukemia. While **Acute Megakaryoblastic Leukemia (AML-M7)** is highly specific and common before age 3, **ALL** is actually more common overall in these patients after the age of 3. 3. **Early-onset Alzheimer’s Disease:** The **Amyloid Precursor Protein (APP) gene** is located on Chromosome 21 [2]. Triple dosage of this gene leads to accelerated beta-amyloid plaque deposition, causing virtually all Down’s patients to develop neuropathological changes of Alzheimer’s by age 40 [1]. **Why other options are incorrect:** Options B, C, and D include **CNS tumors**. While Down’s syndrome patients have an increased risk of leukemias and germ cell tumors, they paradoxically have a **lower incidence of solid tumors** (like CNS tumors or neuroblastomas) compared to the general population, likely due to an extra copy of tumor-suppressor genes like *ETS2*. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause:** Meiotic non-disjunction (95%), strongly associated with advanced maternal age [4]. * **Gastrointestinal:** Associated with Duodenal atresia ("Double bubble sign") and Hirschsprung disease. * **Musculoskeletal:** Atlanto-axial instability. * **Screening:** First-trimester screening shows **increased nuchal translucency**, decreased PAPP-A, and increased free β-hCG. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Manifestations Of Central And Peripheral Nervous System Disease, pp. 720-721. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, pp. 1290-1292. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 171-172. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 40-41.

Question 1000: Graft rejection is primarily mediated by which of the following mechanisms?

A. Cell-mediated immunity
B. Humoral immunity
C. Both cell-mediated and humoral immunity (Correct Answer)
D. Neither cell-mediated nor humoral immunity

Explanation: ### Explanation Graft rejection is a complex immunological process where the recipient's immune system recognizes the donor's **MHC (HLA) molecules** as foreign [2]. The correct answer is **Option C** because rejection involves a coordinated attack by both the cellular and humoral arms of the immune system [3]. **1. Why "Both" is Correct:** * **Cell-Mediated Immunity (CMI):** This is the primary and most common mechanism [1]. It involves **CD8+ T-cells** (direct cytotoxicity) and **CD4+ T-cells** (delayed-type hypersensitivity) [2]. T-cells recognize foreign HLA antigens, leading to inflammation and destruction of the graft parenchyma [1]. * **Humoral Immunity:** This involves the production of **anti-HLA antibodies** by B-cells [2]. These antibodies cause damage through complement activation, Antibody-Dependent Cellular Cytotoxicity (ADCC), and vascular endothelial injury (rejection vasculitis) [4]. **2. Why Other Options are Incorrect:** * **Option A & B:** While CMI is often the dominant feature in acute cellular rejection and Humoral immunity is dominant in hyperacute rejection, they do not act in isolation [3]. Most clinical rejection episodes (especially Acute and Chronic) involve a synergy of both T-cells and B-cells [1]. Choosing only one provides an incomplete picture of the pathophysiology. * **Option D:** This is incorrect as graft rejection is, by definition, an immune-mediated response. **Clinical Pearls for NEET-PG:** * **Hyperacute Rejection:** Occurs within minutes; mediated by **pre-formed antibodies** (Humoral) [3]. Characterized by fibrinoid necrosis and thrombosis. * **Acute Rejection:** Occurs days to weeks; can be **Cellular** (T-cell interstitial infiltrate) or **Humoral/Vascular** (rejection vasculitis) [3]. * **Chronic Rejection:** Occurs months to years; characterized by **intimal thickening** and fibrosis (obliterative intimal proliferation). * **Direct Pathway:** Recipient T-cells recognize donor APCs (most important in early acute rejection) [2]. * **Indirect Pathway:** Recipient T-cells recognize donor antigens presented by recipient APCs (重要 in chronic rejection) [5]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 180-181. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, p. 240. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, p. 242. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 213-214. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 240-241.

Practice by Chapter

Cell Injury and Cell Death

Practice Questions

Adaptations of Cellular Growth

Practice Questions

Accumulations and Deposits

Practice Questions

Acute and Chronic Inflammation

Practice Questions

Tissue Repair and Wound Healing

Practice Questions

Hemodynamic Disorders

Practice Questions

Genetic Disorders

Practice Questions

Environmental Pathology

Practice Questions

Nutritional Diseases

Practice Questions

Molecular Basis of Disease

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free